POSTER: AML-377 Venetoclax in Combination With Low-Dose Cytarabine and/or Actinomycin D in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) Patients With IDH1 or IDH2 Mutations
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
AML,IDH-1,IDH-2,ACTIVE,venetoclax
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要